|
Post by jckrdu on Nov 4, 2014 23:15:49 GMT
Questions #1 and #2 answered on my list above. November 20th. Lots of cash in the bank. Low market cap looks like a bargain. Geographic atrophy rate tracking preclinicals which were outstanding. Perhaps getting early stage AMD data November 20th. I anticipate I'll jump partially out of Geron once abstracts released and into stem until data and then over to BCLI for their data release..... If BCLI data before November 20 I'll miss out there..... Thanks for the information bigmike. On their cash position, do you know how much they have in the bank (as of any date) and what their annual or quarterly burn rate is?
|
|